From the editor: What is the bottom line for clinical lipidology research?
Publication
, Journal Article
Guyton, JR
Published in: J Clin Lipidol
2018
Duke Scholars
Published In
J Clin Lipidol
DOI
ISSN
1933-2874
Publication Date
2018
Volume
12
Issue
5
Start / End Page
1083 / 1084
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Lipid Metabolism
- Humans
- Cardiovascular System & Hematology
- Biomedical Research
- 3205 Medical biochemistry and metabolomics
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Guyton, J. R. (2018). From the editor: What is the bottom line for clinical lipidology research? J Clin Lipidol, 12(5), 1083–1084. https://doi.org/10.1016/j.jacl.2018.09.004
Guyton, John R. “From the editor: What is the bottom line for clinical lipidology research?” J Clin Lipidol 12, no. 5 (2018): 1083–84. https://doi.org/10.1016/j.jacl.2018.09.004.
Guyton JR. From the editor: What is the bottom line for clinical lipidology research? J Clin Lipidol. 2018;12(5):1083–4.
Guyton, John R. “From the editor: What is the bottom line for clinical lipidology research?” J Clin Lipidol, vol. 12, no. 5, 2018, pp. 1083–84. Pubmed, doi:10.1016/j.jacl.2018.09.004.
Guyton JR. From the editor: What is the bottom line for clinical lipidology research? J Clin Lipidol. 2018;12(5):1083–1084.
Published In
J Clin Lipidol
DOI
ISSN
1933-2874
Publication Date
2018
Volume
12
Issue
5
Start / End Page
1083 / 1084
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Lipid Metabolism
- Humans
- Cardiovascular System & Hematology
- Biomedical Research
- 3205 Medical biochemistry and metabolomics
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
- 1101 Medical Biochemistry and Metabolomics